GENEVA The World Health Organization (WHO) on Thursday listed the Pfizer/BioNTech vaccine as the first such drug to receive its emergency validation since
WHO Lists Pfizer/BioNTech Vaccine as First Best Emergency Use Published January 1st, 2021 - 10:21 GMT
A woman reads a copy of the Silent Patient by author Alex Michaelides as she queues at an NHS Covid-19 vaccination centre for the Pfizer-BioNTech Covid-19 vaccine in London on December 30, 2020 as cases of the virus continue to soar and the Government raises restrictions around the country. Britain on December 30 became the first country in the world to approve AstraZeneca and Oxford University s low-cost Covid vaccine, raising hopes it will help tackle surging cases and ease pressure on creaking health services. As daily Covid infection rates hit record highs, the government is pinning its hopes on the Oxford/AstraZeneca jab, which is cheaper to produce, and easier to store and transport. JUSTIN TALLIS / AFP
Vaccinating the planet will take time, says WHO chief aa.com.tr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aa.com.tr Daily Mail and Mail on Sunday newspapers.
More
By allowing ads to appear on this site, you support the local businesses who, in turn, support great journalism. East Georgia receives first vaccines COVID cases, hospitalizations still rising in Ga., US Pictured, Gayle Cousar, RN, receives a COVID-19 vaccination from Jenny Maddi, RN, on Monday at the hospital. (Photo Courtesy East Georgia Regional Medical Center)
East Georgia Regional Medical Center received its first shipment of COVID-19 vaccine from Moderna on Monday, said the hospital’s Director of Marketing Erin Spillman.
“Our plan is that the first to receive vaccinations will be health care personnel who provide direct care to the most vulnerable populations and in their line of work have a high likelihood of contact with COVID-positive patients,” she said. “Also, those who are integral to (the hospital’s) health care structure and the response to the pandemic will
TMCnet News
Pluristem Enters Collaboration With Pharmaceutical Company Innovare R&D to Expand Pluristem s ARDS Associated With COVID-19 Program to Mexico
[December 29, 2020]
Pluristem Enters Collaboration With Pharmaceutical Company Innovare R&D to Expand Pluristem s ARDS Associated With COVID-19 Program to Mexico
HAIFA, Israel, Dec. 29, 2020 (GLOBE NEWSWIRE) (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a platform of novel biological therapeutic products, announced today it has entered into a collaboration agreement with Mexican pharmaceutical company Innovare R&D to expand its ongoing clinical program of PLX cells in the treatment of Acute Respiratory Distress Syndrome (ARDS) associated with COVID-19 in Mexico. The Phase II study in Mexico is subject to the approval of local authorities, with the goal of being conducted under the U.S. Food and Drug Administration (FDA) cleared